siRNA treatment decreases triglycerides in individuals along with uncommon problem

.RESEARCH EMPHASIZE.19 September 2024.

Plozasiran lessened triglyceride levels by 80% and also lowered the risk of pancreatitis in people with persistent chylomicronemia, along with or without a genetic medical diagnosis.